The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.
Open accessAbstract
A Mr 35,000 protein with follicle-stimulating hormone release-inhibitory activity was isolated from porcine ovarian follicular fluid by heparin-Sepharose affinity chromatography, gel filtration on Sephacryl S-200, and multiple steps of high-performance liquid chromatography. The isolated molecule is highly enriched in cysteines and is composed of a single polypeptide chain. In addition, it has no sequence homology with the previously characterized follicular fluid inhibins, which are heterodimeric proteins of Mr 32,000 with follicle-stimulating hormone release-inhibiting activity. This protein specifically inhibits the basal secretion of follicle-stimulating hormone, but not that of luteinizing hormone, in the rat anterior pituitary monolayer culture system with a half-maximal effective dose of 2.5-6.0 ng/ml. Another form of the molecule of Mr 32,000 present in much lower concentration in follicular fluid was also isolated. It may differ from the Mr 35,000 form in glycosylation or carboxyl-terminal truncation. We suggest that this compound be called "follistatin" to signify its structural difference from inhibin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid
Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D., & Spiess, J. (1986) · Nature · doi:10.1038/321776a0 · Cited by 1,154
Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin
Ling, N., Ying, S.-Y., Ueno, N., Shimasaki, S., Esch, F., Hotta, M., & Guillemin, R. (1986) · Nature · doi:10.1038/321779a0 · Cited by 1,081
Self-citationMason, A. J., Hayflick, J. S., Ling, N., Esch, F., Ueno, N., Ying, S.-Y., Guillemin, R., Niall, H., & Seeburg, P. H. (1985) · Nature · doi:10.1038/318659a0 · Cited by 713
Self-citationIsolation of inhibin from bovine follicular fluid
Robertson, D. M., Foulds, L. M., Leversha, L., Morgan, F. J., Hearn, M. T. W., Burger, H. G., Wettenhall, R. E. H., & de Kretser, D. M. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90594-7 · Cited by 494
Dual Endocrine Activity of the Testes
McCullagh, D. R. (1932) · Science · doi:10.1126/science.76.1957.19 · Cited by 451
Ling, N., Ying, S. Y., Ueno, N., Esch, F., Denoroy, L., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7217 · Cited by 435
Self-citationIsolation of porcine follicular fluid inhibin of 32K daltons
Miyamoto, K., Hasegawa, Y., Fukuda, M., Nomura, M., Igarashi, M., Kangawa, K., & Matsuo, H. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90164-0 · Cited by 327
Purification and partial characterization of inhibin from porcine follicular fluid
Rivier, J., Spiess, J., McClintock, R., Vaughan, J., & Vale, W. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91849-2 · Cited by 291
Forage, R. G., Ring, J. M., Brown, R. W., McInerney, B. V., Cobon, G. S., Gregson, R. P., Robertson, D. M., Morgan, F. J., Hearn, M. T., & Findlay, J. K. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3091 · Cited by 275
Williams' Textbook of Endocrinology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_9 · Cited by 247
Cited by
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883
YING, S.-Y. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-267 · Cited by 820
Self-citationThe Bone Morphogenetic Protein System In Mammalian Reproduction
Shimasaki, S., Moore, R. K., Otsuka, F., & Erickson, G. F. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0007 · Cited by 741
Self-citationThe Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H., & Miyazono, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.217 · Cited by 496
Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 443
The endocrine function of human placenta: an overview
Costa, M. A. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.10.005 · Cited by 368
Peptide Signaling in Human Placenta and Membranes: Autocrine, Paracrine, and Endocrine Mechanisms*
PETRAGLIA, F., FLORIO, P., NAPPI, C., & GENAZZANI, A. R. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-156 · Cited by 352
Welt, C., Sidis, Y., Keutmann, H., & Schneyer, A. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700905 · Cited by 324
Francois, V, Solloway, M., O'Neill, J. W., Emery, J., & Bier, E. (1994) · Genes & Development · doi:10.1101/gad.8.21.2602 · Cited by 308
“The other well-studied class of inhibitors of the TGF-p class of growth factors is follistatin (Robertson et al. 1987; Ueno et al. 1987), which inactivates activin by binding to it stochiometrically (Nakamura et al. 1990).”
BackgroundGnessi, L., Fabbri, A., & Spera, G. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0310 · Cited by 306
Diabetes-induced hyperglycemia impairs male reproductive function: A systematic review
Maresch, C. C., Stute, D. C., Alves, M. G., Oliveira, P. F., de Kretser, D. M., & Linn, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx033 · Cited by 294
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
“Activins are antagonized by follistatin, an activin-binding protein that affects the accessibility of activins to their receptors thereby attenuating activin-mediated FSH release, a function from which its name is derived (Esch et al. 1987; Ueno et al. 1987; Nakamura et al. 1990; Sidis et al. 2006).”
Follistatin: A Multifunctional Regulatory Protein
Phillips, D. J., & de Kretser, D. M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0169 · Cited by 275
Miralles, F., Czernichow, P., & Scharfmann, R. (1998) · Development · doi:10.1242/dev.125.6.1017 · Cited by 275
SHIBANUMA, M., MASHIMO, J., MITA, A., KUROKI, T., & NOSE, K. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18212.x · Cited by 274
Evidence for an Autocrine Role of Activin B within Rat Anterior Pituitary Cultures
Corrigan, A. Z., Bilezikjian, L. M., Carroll, R. S., Bald, L. N., Schmelzer, C. H., Fendly, B. M., Mason, A. J., Chin, W. W., Schwall, R. H., & Vale, W. (1991) · Endocrinology · doi:10.1210/endo-128-3-1682 · Cited by 261
Activin Receptors and Cellular Signaling by the Receptor Serine Kinase Family
MATHEWS, L. S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-310 · Cited by 260
Follistatin Binds to both Activin and Inhibin through the Common Beta-Subunit
Shimonaka, M., Inouye, S., Shimasaki, S., & Ling, N. (1991) · Endocrinology · doi:10.1210/endo-128-6-3313 · Cited by 258
Self-citationPrimary structure of the human follistatin precursor and its genomic organization
Shimasaki, S., Koga, M., Esch, F., Cooksey, K., Mercado, M., Koba, A., Ueno, N., Ying, S. Y., Ling, N., & Guillemin, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4218 · Cited by 232
Self-citationInhibins, activins and follistatin in reproduction
de Kretser, D. M. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.529 · Cited by 211
“Further studies of proteins in ovarian follicular ¯uid enabled the isolation of another FSH-suppressing protein termed follistatin, that bore no signi®cant homology to the a-and b-subunits of the inhibin/activin family (Robertson et al., 1987; Ueno et al., 1987).”
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Nakamura, T., Sugino, K., Titani, K., & Sugino, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55015-8 · Cited by 166
Neuroendocrine Control of the Ovarian Cycle of the Rat
Levine, J. E. (2015) · Knobil and Neill's Physiology of Reproduction · doi:10.1016/b978-0-12-397175-3.00026-0 · Cited by 140
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104
Eldar-Geva, T., Spitz, I. M., Groome, N. P., Margalioth, E. J., & Homburg, R. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2552 · Cited by 94
“Follistatin is a monomeric glycosylated polypeptide chain, which was initially identified in and isolated from follicular fluid on the basis of its inhibition of pituitary FSH secretion (Robertson et al., 1987; Ueno et al., 1987).”
BackgroundOwens, L. A., Kristensen, S. G., Lerner, A., Christopoulos, G., Lavery, S., Hanyaloglu, A. C., Hardy, K., Yding Andersen, C., & Franks, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00780 · Cited by 85
Myostatin: a skeletal muscle chalone
Lee, S.-J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012422-112116 · Cited by 84
Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay
Schneyer, A. L., Wang, Q., Sidis, Y., & Sluss, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0162 · Cited by 71
Circulating follistatin in relation to energy metabolism
Hansen, J. S., & Plomgaard, P. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.002 · Cited by 62
Clinical and therapeutic implications of follistatin in solid tumours
SHI, L., RESAUL, J., OWEN, S., YE, L., & JIANG, W. G. (2016) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20005 · Cited by 47
Reis, F. M., Luisi, S., Abrao, M. S., Rocha, A. L. L., Vigano, P., Rezende, C. P., Florio, P., & Petraglia, F. (2012) · Human Reproduction · doi:10.1093/humrep/des055 · Cited by 43
Regulation of the expression of follistatin in rat hepatocytes
Zhang, Y.-Q., Kanzaki, M., Shibata, H., & Kojima, I. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00085-7 · Cited by 36
Lee, S.-J. (2012) · Muscle · doi:10.1016/b978-0-12-381510-1.00079-x · Cited by 8
Metadata
- Authors
- Ueno, N., Ling, N., Ying, S. Y., Esch, F., Shimasaki, S., & Guillemin, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-12
- Volume
- 84
- Issue
- 23
- Pages
- 8282-8286
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2031399745
- Cited by
- 445
- References
- 17
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.